Latest News

Filters

Filter by tags: Medicine Clear all tag filters

21 news articles found

The aim is to have production lines operating at the plant in Obninsk by 2025, supplying products for the diagnosis and treatment of patients, including a wide range of cancers. Rosatom says it will ensure Russia's sovereignty in the production of radiopharmaceuticals.

Source: World Nuclear News
Date: Wednesday, 25 January 2023
Original article: world-nuclear-news.org/Articles/Construction-starts-for-Russian-medical-isotopes-p

Bangladesh is committed to continuous improvement of nuclear and radiation safety, an International Atomic Energy Agency (IAEA) team of experts has concluded. The Integrated Regulatory Review Service (IRRS) mission team identified areas for possible improvements.

Source: World Nuclear News
Date: Friday, 16 December 2022
Original article: world-nuclear-news.org/Articles/IAEA-says-Bangladesh-committed-to-nuclear-safety

The UK National Nuclear Laboratory (NNL) said on 30 May that it had made a breakthrough for producing the medical radioisotope Lead-212, a key cancer treatment, which is difficult to produce. Lead-212 limits the side effects of cancer treatment because it is delivered directly to cancerous cells. Currently the supply of Lead-212 faces a global shortage which constrains its use, with no production route in existence in the UK.

Source: NEI Magazine
Date: Wednesday, 08 June 2022
Original article: neimagazine.com/news/newsnnl-makes-breakthrough-in-production-of-lead-212-9754927

Scientists at the UK's National Nuclear Laboratory (NNL) have developed a process for producing the country's first domestically produced supply of the medical radioisotope lead-212 (Pb-212).

Source: World Nuclear News
Date: Wednesday, 01 June 2022
Original article: world-nuclear-news.org/Articles/NNL-breakthrough-to-boost-medical-radioisotope-sup

Specialists from twenty-one countries in Africa have for the first time formed an African Association of Radiopharmacy (AfrAR) to strengthen their capacities and better meet national needs for the safe preparation and administration of radiopharmaceuticals used in diagnosing, treating and managing cancer and other diseases, the International Atomic Energy Agency (IAEA) said on 12 April. 

Source: NEI Magazine
Date: Friday, 15 April 2022
Original article: neimagazine.com/news/newsfirst-african-association-of-radiopharmacy-established-9630017

The High Flux Reactor (HFR) in Petten in the Netherlands – a major source of medical isotopes – was restarted on 17 March, NRG announced.

Source: NEI Magazine
Date: Tuesday, 22 March 2022
Original article: neimagazine.com/news/newsnetherlands-hfr-restarts-9563663

The Australian Nuclear Science and Technology Organisation (ANSTO) and Canada’s Terrestrial Energy have agreed to explore ANSTO Synroc (synthetic rock) proprietary waste treatment technology for used fuel management.

Source: NEI Magazine
Date: Friday, 04 February 2022
Original article: neimagazine.com/news/newsterrestrial-energy-and-ansto-sign-agreement-for-used-fuel-management-9459924

The nuclear medicine sector is a small part of the wider nuclear industry, but it provides some of the most pioneering technologies in healthcare - and is close to making personalised medicine a reality. Antonis Kalemis, president of Nuclear Medicine Europe and business manager for molecular imaging at Siemens Healthineers, describes how nuclear medicine also tackles the most trenchant condition in modern healthcare: cancer.

Source: World Nuclear News
Date: Thursday, 29 July 2021
Original article: world-nuclear-news.org/Articles/Viewpoint-Nuclear-medicine-is-crucial-for-fighting

Radioisotopes essential for diagnostics and treatment of severe diseases Brussels-based nuclear industry association Foratom has called on the European Union to better recognise and support the medical applications of nuclear technology, which play a significant role in the medical sector and help “save thousands of lives each day.”

Foratom said in a joint position paper with Nuclear Medicine Europe that EU policy makers should find ways of promoting new research reactor capacity along with innovation in the sector, and implement a number of recommendations to maintain the current level of medical radioisotopes supply.

According to the paper, in order to ensure that the supply of medical radioisotopes will be continued, the EU needs to develop a “robust” supply chain which goes beyond irradiation, adapt clinical research and development of new radiopharmaceutical compounds, and reconsider reimbursement systems for radiopharmaceutical products.

Source: Nucnet
Date: Wednesday, 16 June 2021
Original article: nucnet.org/news/foratom-urges-european-union-to-provide-more-support-for-nuclear-medicine-6-2-2021

Europe must take action to maintain the current level of medical radioisotopes supply, according to a joint position paper from Foratom, the European nuclear trade body, and Nuclear Medicine Europe, which represents pharmaceutical and imaging equipment companies in the field of nuclear medicine. They say the European Union should promote new research reactor capacity along with innovation in the sector and the design modification of the current fleet.

Source: World Nuclear News
Date: Wednesday, 16 June 2021
Original article: world-nuclear-news.org/Articles/EU-industry-bodies-call-for-more-support-for-nucle

Load more news